These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26172303)

  • 1. Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer.
    Litchfield LM; Mukherjee A; Eckert MA; Johnson A; Mills KA; Pan S; Shridhar V; Lengyel E; Romero IL
    Oncotarget; 2015 Sep; 6(27):23548-60. PubMed ID: 26172303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models.
    Lengyel E; Litchfield LM; Mitra AK; Nieman KM; Mukherjee A; Zhang Y; Johnson A; Bradaric M; Lee W; Romero IL
    Am J Obstet Gynecol; 2015 Apr; 212(4):479.e1-479.e10. PubMed ID: 25446664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis.
    Yoshida M; Taguchi A; Kawana K; Adachi K; Kawata A; Ogishima J; Nakamura H; Fujimoto A; Sato M; Inoue T; Nishida H; Furuya H; Tomio K; Arimoto T; Koga K; Wada-Hiraike O; Oda K; Nagamatsu T; Kiyono T; Osuga Y; Fujii T
    PLoS One; 2016; 11(8):e0160330. PubMed ID: 27483433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3).
    Rogalska A; Forma E; Bryś M; Śliwińska A; Marczak A
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30217067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway.
    Wang X; Duan W; Li X; Liu J; Li D; Ye L; Qian L; Yang A; Xu Q; Liu H; Fu Q; Wu E; Ma Q; Shen X
    Oncotarget; 2015 Dec; 6(38):40959-69. PubMed ID: 26516926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention.
    Zordoky BN; Bark D; Soltys CL; Sung MM; Dyck JR
    Biochim Biophys Acta; 2014 Jun; 1840(6):1943-57. PubMed ID: 24462945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells.
    Ariaans G; Jalving M; Vries EG; Jong S
    BMC Cancer; 2017 Mar; 17(1):232. PubMed ID: 28356082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon source and myc expression influence the antiproliferative actions of metformin.
    Javeshghani S; Zakikhani M; Austin S; Bazile M; Blouin MJ; Topisirovic I; St-Pierre J; Pollak MN
    Cancer Res; 2012 Dec; 72(23):6257-67. PubMed ID: 23041548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine kinase inhibitor imatinib modulates the viability and apoptosis of castrate-resistant prostate cancer cells dependently on the glycolytic environment.
    Cardoso HJ; Vaz CV; Carvalho TMA; Figueira MI; Socorro S
    Life Sci; 2019 Feb; 218():274-283. PubMed ID: 30605651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer.
    Mondal S; Roy D; Camacho-Pereira J; Khurana A; Chini E; Yang L; Baddour J; Stilles K; Padmabandu S; Leung S; Kalloger S; Gilks B; Lowe V; Dierks T; Hammond E; Dredge K; Nagrath D; Shridhar V
    Oncotarget; 2015 Oct; 6(32):33705-19. PubMed ID: 26378042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer.
    Qiu H; Jackson AL; Kilgore JE; Zhong Y; Chan LL; Gehrig PA; Zhou C; Bae-Jump VL
    Oncotarget; 2015 Mar; 6(9):6915-30. PubMed ID: 25762632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer Effects of γ-Tocotrienol Are Associated with a Suppression in Aerobic Glycolysis.
    Parajuli P; Tiwari RV; Sylvester PW
    Biol Pharm Bull; 2015; 38(9):1352-60. PubMed ID: 26328490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of hyperglycemia on cerebral metabolism during hypoxia-ischemia in the immature rat.
    Vannucci RC; Brucklacher RM; Vannucci SJ
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):1026-33. PubMed ID: 8784248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
    Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
    Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro.
    Dykens JA; Jamieson J; Marroquin L; Nadanaciva S; Billis PA; Will Y
    Toxicol Appl Pharmacol; 2008 Dec; 233(2):203-10. PubMed ID: 18817800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy and protein kinase RNA-like endoplasmic reticulum kinase (PERK)/eukaryotic initiation factor 2 alpha kinase (eIF2α) pathway protect ovarian cancer cells from metformin-induced apoptosis.
    Moon HS; Kim B; Gwak H; Suh DH; Song YS
    Mol Carcinog; 2016 Apr; 55(4):346-56. PubMed ID: 25663310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction.
    Bakhashab S; Ahmed FW; Schulten HJ; Bashir A; Karim S; Al-Malki AL; Gari MA; Abuzenadah AM; Chaudhary AG; Alqahtani MH; Lary S; Ahmed F; Weaver JU
    Cardiovasc Diabetol; 2016 Feb; 15():27. PubMed ID: 26861446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of metformin.
    Kato K; Iwama H; Yamashita T; Kobayashi K; Fujihara S; Fujimori T; Kamada H; Kobara H; Masaki T
    Oncol Rep; 2016 Mar; 35(3):1582-92. PubMed ID: 26708419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin inhibits the development and metastasis of ovarian cancer.
    Wu B; Li S; Sheng L; Zhu J; Gu L; Shen H; La D; Hambly BD; Bao S; Di W
    Oncol Rep; 2012 Sep; 28(3):903-8. PubMed ID: 22752027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.